Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1104612 | 0.95 | CYP1A2 (0.35) | CYP1A2SMN1; SMN2 | |
| SCHEMBL12313901 | 0.91 | TSHR (0.37) | SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL19929368 | 0.87 | TSHR (0.42) | CYP1A2SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL15440624 | 0.86 | TSHR (0.35) | SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL4122685 | 0.86 | TSHR (0.35) | SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL15672320 | 0.86 | TSHR (0.35) | SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL1104616 | 0.84 | CYP1A2 (0.41) | CYP1A2SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL12604000 | 0.84 | SMN1; SMN2 (0.32) | SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL12988459 | 0.82 | SMN1; SMN2 (0.33) | SMN1; SMN2TSHRALDH1A1TDP1 | |
| SCHEMBL10034835 | 0.81 | TSHR (0.39) | SMN1; SMN2TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8715863-B2 | Battery having electrolyte with mixed solvent | QUALLION LLC (US) | 2014-05-06 | — | — | US | disclosed |
| US-20120171578-A1 | Battery having electrolyte with mixed solvent | QUALLION LLC | 2012-07-05 | — | — | US | disclosed |
| US-20120115041-A1 | ELECTROCHEMICAL DEVICE HAVING ELECTROLYTE INCLUDING DISILOXANE | WEST ROBERT C (US) | 2012-05-10 | — | — | US | disclosed |
| US-8153307-B1 | Battery including electrolyte with mixed solvent | QUALLION LLC (US) | 2012-04-10 | — | — | US | disclosed |
| US-7771496-B1 | Reduction of impurities in battery electrolyte | QUALLION LLC (US) | 2010-08-10 | — | — | US | disclosed |
| US-7718321-B2 | Lithium difluoro oxalatoborate in silane or siloxane is electrolyte; one or more anodes that include two or three components selected from of carbon beads, carbon fibers, and graphite flakes; good discharge capacity retention after formation of a passivation layer | QUALLION LLC (US) | 2010-05-18 | — | — | US | disclosed |
| US-7598003-B1 | Includes lithium bis[bidentate]borate or lithium dihalo mono[bidentate]borate | QUALLION LLC (US) | 2009-10-06 | — | — | US | disclosed |
| US-20070065728-A1 | Battery having electrolyte with mixed solvent | QUALLION LLC | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115041-A1 | ELECTROCHEMICAL DEVICE HAVING ELECTROLYTE INCLUDING DISILOXANE | HCN4, KCNN4, CA1 | CYP1A2 3244/4885SMN1; SMN2 2039/4885TSHR 4425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.